A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma
Clinical trial NCT00512863 · WITHDRAWN
Trial details
- NCT number
- NCT00512863
- Sponsor
- Abbott
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.